Antibacterial Therapeutics Market: Analysis of strategic consolidations and deals revealed a high level of activity between 2006 and 2017

This report examines the entire antibacterial therapy area with a particular focus on four key indications, methicillin resistant staphylococcus aureus (MRSA), sepsis, pneumonia and tuberculosis, which were selected due to their pipeline size, prevalence and level of unmet need.

Pune, India - March 14, 2018 /MarketersMedia/ —

Antibacterial resistance is currently believed to be responsible for over 700,000 deaths each year. As antibiotic resistance increases, due to the overuse and misuse of antibiotics, the number of avoidable deaths is expected to increase, with one study predicting there will be 10 million deaths caused by bacteria resistant to antibiotics in 2050. There are several techniques being utilized to combat the spread of antibiotic resistance, which range from combining antibiotics to increase efficacy to reducing the use antibiotics in both humans and livestock.
Access Report Details at: https://www.themarketreports.com/report/antibacterial-therapeutics-high-levels-of-pipeline-innovation-focused-on-the-increasing-unmet-need-associated-with-antibiotic-resistance
Scope
• The antibacterial pipeline is large, with 1,634 products in active development. Does current pipeline innovation hold the potential to affect the future antibacterial market?
• The four key indications in the antibacterial pipeline are tuberculosis, pneumonia, MRSA and sepsis. How does the composition of each pipeline compare both in terms of first-in-class and non-first-in-class innovation.
• There are 234 first-in-class products in the antibacterial pipeline. Which of these possess the greatest potential to improve disease outcome and be commercially successful, based on their target?
• Analysis of strategic consolidations and deals revealed a high level of activity between 2006 and 2017.
• A significant number of first-in-class products have been identified with no prior involvement in deals. How does deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935564
Without the development of innovate antibacterial products the emergence and spread of antibiotic resistance will not only increase the number of avoidable deaths caused by the infection itself, it also has the potential to increase the risks associated with surgery, while putting additional pressure on already stretched healthcare providers, as treating drug-resistant infections is considerably more expensive than treating drug-susceptible infections.
Get this report at: https://www.themarketreports.com/report/buy-now/935564

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/antibacterial-therapeutics-market-analysis-of-strategic-consolidations-and-deals-revealed-a-high-level-of-activity-between-2006-and-2017/314320

For more information, please visit https://www.themarketreports.com/report/antibacterial-therapeutics-high-levels-of-pipeline-innovation-focused-on-the-increasing-unmet-need-associated-with-antibiotic-resistance%20

Source: MarketersMedia

Release ID: 314320

Latest News

US stocks rise again; tech and high-dividend companies climb

Dec 13, 2018

NEW YORK — U.S. stocks are mixed in morning trading Thursday as technology and health care companies rise. Safer, high-dividend stocks in real estate and utilities are also climbing. Banks are falling, and smaller companies continue to lag their larger rivals. The European Central Bank said it will end its bond-buying economic stimulus program at the end of the year, but trimmed its forecasts for economic growth across Europe. Government bond yields in Europe are falling. KEEPING SCORE: The S&P 500 index added 5 points, or 0.2 percent, to 2,656 at 10:30 a.m. Eastern time. The Dow Jones Industrial Average...

Eurozone stimulus program to end as growth worries resurface

Dec 13, 2018

FRANKFURT, Germany — The European Central Bank is ending the stimulus program that helped nurse the eurozone economy back to health over the past four years — despite the emergence of new risks including a global trade war and Brexit. Thursday's decision to stop the bank's monthly bond purchases at the end of the year closes out a 2.6-trillion euro ($3 trillion) effort that President Mario Draghi credits with helping put more than 9 million people in jobs. Draghi said at a news conference that at times "it was the only driver of the recovery" in the absence of other...

Oil pipeline opponents look past Minnesota regulators

Dec 13, 2018

MINNEAPOLIS — Opponents of Enbridge Energy's proposed Line 3 crude oil pipeline replacement may turn their attention to fighting the project on other fronts as a Minnesota regulatory panel prepares to take one of its final steps to allow it to proceed. The Public Utilities Commission on Thursday was scheduled to discuss petitions by environmental and tribal groups for the panel to reconsider its decision in June to approve a route permit for the line across northern Minnesota. Those opponents acknowledge that they hold out little hope, given that the commission earlier this month quickly and unanimously rejected their petitions...

The Latest: Low rates expected to support European economy

Dec 13, 2018

FRANKFURT, Germany — The Latest on the European Central Bank's monetary policy meeting (all times local): 2:55 p.m. European Central Bank President Mario Draghi says strong domestic demand and low interest rates are supporting the economy in Europe despite a recent moderation in growth. Draghi said at a news conference Thursday that "the underlying strength of domestic demand continues to underpin the eurozone expansion." He spoke after the bank decided to stop its bond-buying stimulus program, which has helped the economy emerge from its debt crisis four years ago, at the end of this year. Draghi said rising wages gave...

German coalition tries to resolve dispute over abortion law

Dec 13, 2018

BERLIN — Germany's governing coalition is trying to resolve a long-running dispute over a ban on doctors advertising abortions. Chancellor Angela Merkel's junior governing partners, the center-left Social Democrats, want to remove the ban from Germany's criminal code. It provides for a fine or a prison sentence of up to two years. But Merkel's center-right party insists it should stay. Leading ministers on Wednesday hammered out a proposed compromise under which the advertising ban would remain, but the law would be reformed to state more clearly how doctors and hospitals can inform potential patients that they carry out abortions. That...

Search
Financial Markets

About Us

Established in 2015, The Upstocker provides insights on financial reports, commentary, and investment data to traders so that you can make better investment decisions.

Contact us: sales[at]theupstocker.com

Subscribe Now!